Join the fight for democracy and let your voice be heard!

The AGOA Extension Act, designated as H.R. 6500 in the 119th Congress, was introduced on December 9, 2025. The bill aims to extend the African Growth and Opportunity Act (AGOA) and likely contains provisions related to trade and economic cooperation with Africa. Specific details and directives within the bill are not provided in the context object. For more information, the full text of the bill can be accessed via the provided links to the official PDF version.

Bill 119 s 494, also known as the National Epilepsy Coordination and Research Act, is a proposed piece of legislation in the US Congress. The main goal of this bill is to create a national plan that will coordinate research efforts related to epilepsy.

Epilepsy is a neurological disorder that affects the brain and causes seizures. It is estimated that around 3.4 million people in the United States have epilepsy, making it one of the most common neurological conditions in the country. Despite its prevalence, there is still much that is not known about epilepsy and how to effectively treat it.

The National Epilepsy Coordination and Research Act aims to address this issue by bringing together researchers, healthcare providers, and other stakeholders to develop a comprehensive plan for studying epilepsy. This plan will include strategies for improving the understanding of epilepsy, developing new treatments, and ultimately finding a cure for the condition. In addition to coordinating research efforts, the bill also includes provisions for increasing public awareness about epilepsy and improving access to care for individuals with the condition. It also calls for the establishment of a national database to track the prevalence of epilepsy and monitor trends in diagnosis and treatment. Overall, Bill 119 s 494 represents a significant step forward in the fight against epilepsy. By bringing together experts from various fields and creating a coordinated research plan, this legislation has the potential to improve the lives of millions of Americans living with epilepsy.

The bill "A bill to require United States foreign assistance commodities to be made available for their intended purposes before they expire" was introduced in the 119th Congress as Senate Bill 2252 on July 10, 2025.

The bill "A bill to amend the Accelerating Access to Critical Therapies for ALS Act to reauthorize the provisions of such Act through fiscal year 2031, and for other purposes" (S. 4472) was introduced in the 119th Congress on April 30, 2026.

The bill titled "To improve Federal technology procurement, and for other purposes" was introduced in the 119th Congress on June 25, 2025, as H.R. 4123. The purpose of the bill is to enhance the process of Federal technology procurement, though specific provisions or directives are not outlined in the provided context.